Robert Šeparović

863 total citations
36 papers, 157 citations indexed

About

Robert Šeparović is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Robert Šeparović has authored 36 papers receiving a total of 157 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 10 papers in Pulmonary and Respiratory Medicine and 6 papers in Cancer Research. Recurrent topics in Robert Šeparović's work include HER2/EGFR in Cancer Research (10 papers), Cancer Treatment and Pharmacology (7 papers) and Breast Cancer Treatment Studies (6 papers). Robert Šeparović is often cited by papers focused on HER2/EGFR in Cancer Research (10 papers), Cancer Treatment and Pharmacology (7 papers) and Breast Cancer Treatment Studies (6 papers). Robert Šeparović collaborates with scholars based in Croatia, United States and United Kingdom. Robert Šeparović's co-authors include Božo Krušlin, Antonio Juretić, Marija Gamulin, Giulio C. Spagnoli, Elke Schultz‐Thater, Michael Heberer, Luigi Terracciano, Zdenko Krajina, Božena Šarčević and Žarko Bajić and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Robert Šeparović

32 papers receiving 154 citations

Peers

Robert Šeparović
Koichi Onodera Japan
Marie Mack United States
Tatjana Božanović Serbia
Alejandra Wernicke Argentina
Viola Ghizzoni Italy
Haocan Song United States
Anne Sibille Belgium
Sara Delfanti Italy
Shunzeng Lv China
Ravichandra Karra Gurunath France
Koichi Onodera Japan
Robert Šeparović
Citations per year, relative to Robert Šeparović Robert Šeparović (= 1×) peers Koichi Onodera

Countries citing papers authored by Robert Šeparović

Since Specialization
Citations

This map shows the geographic impact of Robert Šeparović's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Šeparović with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Šeparović more than expected).

Fields of papers citing papers by Robert Šeparović

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Šeparović. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Šeparović. The network helps show where Robert Šeparović may publish in the future.

Co-authorship network of co-authors of Robert Šeparović

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Šeparović. A scholar is included among the top collaborators of Robert Šeparović based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Šeparović. Robert Šeparović is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Šeparović, Robert, et al.. (2025). Trastuzumab and cardiotoxicity. SHILAP Revista de lepidopterología. 52(2-3). 110–118. 1 indexed citations
3.
Šeparović, Robert, et al.. (2024). Globalization of clinical research in oncology: Status, challenges, and future directions. Journal of Cancer Policy. 42. 100500–100500. 3 indexed citations
4.
5.
Šeparović, Robert, et al.. (2022). Comprehensive Genomic Profiling in the Management of Ovarian Cancer—National Results from Croatia. Journal of Personalized Medicine. 12(7). 1176–1176. 2 indexed citations
6.
7.
Šeparović, Robert, et al.. (2021). Immunity and cancer: role of tumor-infiltrating lymphocytes in triple-negative breast cancer. SHILAP Revista de lepidopterología. 49(1). 20–28.
8.
Šeparović, Robert, et al.. (2020). Characteristics and Prognosis of Triple-Negative Breast Cancer Patients: a Croatian Single Institution Retrospective Cohort Study. SHILAP Revista de lepidopterología. 1 indexed citations
9.
Vrdoljak, Eduard, Stjepko Pleština, Antonio Juretić, et al.. (2018). CLINICAL GUIDELINES FOR DIAGNOSIS, TREATMENT AND MONITORING PATIENTS WITH COLORECTAL CANCER. University of Zagreb University Computing Centre (SRCE). 140(9-10). 241–247. 4 indexed citations
10.
Jakopović, Marko, et al.. (2018). [CANCER PATIENTS FOLLOW-UP – CROATIAN SOCIETY FOR MEDICAL ONCOLOGY CLINICAL GUIDELINES Part V: melanoma, sarcomas, central nerve system tumors, lung cancer].. PubMed. 139(1-2). 17–23. 2 indexed citations
11.
Šeparović, Robert, et al.. (2018). CANCER PATIENTS FOLLOW-UP – CROATIAN SOCIETY OF MEDICAL ONCOLOGY CLINICAL GUIDELINES Part I: breast cancer, uterine cancer, cervical cancer, ovarian cancer.. PubMed. 138(3-4). 167–72. 1 indexed citations
12.
Šeparović, Robert, et al.. (2018). Rapid hair depigmentation in patient treated with pazopanib. BMJ Case Reports. 2018. bcr–2018. 3 indexed citations
13.
Jiménez, M. Martín, Bent Ejlertsen, Suzette Delaloge, et al.. (2017). Neratinib after trastuzumab (T)-based adjuvant therapy in early-stage HER2+ breast cancer (BC): 5-year analysis of the phase III ExteNET trial. Annals of Oncology. 28. v43–v44. 3 indexed citations
14.
Šeparović, Robert, et al.. (2016). Cannabis in oncology. 44. 51–57. 1 indexed citations
15.
Čeović, Romana, Snježana Dotlić, Ivana Ilić, et al.. (2016). [CROATIAN SOCIETY FOR MEDICAL ONCOLOGY CLINICAL GUIDELINES FOR DIAGNOSIS, TREATMENT AND FOLLOW-UP OF PATIENTS WITH MELANOMA].. PubMed. 138(1-2). 22–9. 2 indexed citations
16.
Šeparović, Robert, Željko Soldić, Paula Podolski, et al.. (2015). [CLINICAL GUIDELINES FOR DIAGNOSIS, TREATMENT AND MONITORING OF PATIENTS WITH INVASIVE BREAST CANCER--CROATIAN ONCOLOGY SOCIETY].. PubMed. 137(5-6). 143–9. 1 indexed citations
17.
Šeparović, Robert, et al.. (2014). Systemic therapy of early breast cancer. Hrčak Portal of scientific journals of Croatia (University Computing Centre).
18.
Juretić, Antonio, et al.. (2011). Expression of MAGE-A and NY-ESO-1 cancer/testis antigens in medullary breast cancer: a retrospective immunohistochemical study. Croatian Medical Journal. 52(2). 171–177. 14 indexed citations
19.
Šarčević, Boris, et al.. (1999). Prognostic value of prominent DCIS component in the breast-conserving therapy of stage I and II invasive ductal breast cancer. The Breast. 8(2). 72–76. 3 indexed citations
20.
Šeparović, Robert, et al.. (1998). Unusual features of metastatic atypical carcinoid of the larynx. European Archives of Oto-Rhino-Laryngology. 255(6). 318–321. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Koichi Onodera Breakdown of academic impact, for papers by Marie Mack Breakdown of academic impact, for papers by Tatjana Božanović Breakdown of academic impact, for papers by Alejandra Wernicke Breakdown of academic impact, for papers by Viola Ghizzoni Breakdown of academic impact, for papers by Haocan Song Breakdown of academic impact, for papers by Anne Sibille Breakdown of academic impact, for papers by Sara Delfanti Breakdown of academic impact, for papers by Shunzeng Lv Breakdown of academic impact, for papers by Ravichandra Karra Gurunath
Rankless by CCL
2026